“It’s a high-risk population, and we’re trying to improve outcomes for these patients,” said Dr. Juan Pablo Alderuccio, an associate professor of medicine and hematologist at Sylvester, first author and presenter of the abstract, which ASH has designated a clinically relevant presentation.